资讯库
更紧凑的生命科学资讯库。
先搜索，再按来源或主题继续收窄。
罗氏签署超2亿美元许可协议，引进Freenome癌症筛查血液检测技术
Roche will make a new $75 million equity investment in Freenome, toward the goal of developing blood testing kits for markets outside the U.S.
大卫·罗奇预计未来六个月市场将出现可控调整 - 《经济时报》
David Roche expects controlled market correction in next six months The Economic Times
纳斯达克精选报告：Alphabet、罗氏与RTX股票分析
Top Stock Reports for Alphabet, Roche & RTX Nasdaq
Lineage Cell宣布达成与罗氏协议中OpRegen的首个研发里程碑——TipRanks
Lineage Cell says first OpRegen development milestone under Roche pact achieved TipRanks
Veeva宣布扩大与罗氏的合作关系 - MarketScreener
Veeva Announces Expanded Partnership with Roche MarketScreener
罗氏采用Veeva Vault CRM系统——合同制药领域新动态
Roche Adopts Veeva Vault CRM Contract Pharma
湖人队史15号球衣——约翰·罗奇 - 勒布朗连线
Lakers jersey history No. 15 — John Roche LeBron Wire
斯蒂芬·M·罗什讣告 - 邦德殡仪馆，2025年11月22日
Stephen M. Roche Obituary November 22, 2025 Bond Funeral Home
罗氏签署2亿美元协议，引进Freenome癌症筛查血液检测技术——Fierce Biotech报道
Roche inks $200M pact for Freenome's cancer screening blood test Fierce Biotech
罗氏签署协议，获得Freenome癌症检测在美国以外地区的使用权 - MedTech Dive
Roche inks deal for rights to Freenome cancer tests outside US MedTech Dive
Regeneron获两项Eylea批准，加剧与罗氏竞争 - 激烈医药市场动态
Regeneron wins 2 Eylea nods, ramping up competition with Roche Fierce Pharma
瑞银维持对罗氏控股(RHHVF)的买入评级 - 环球邮报
UBS Sticks to Its Buy Rating for Roche Holding AG (RHHVF) The Globe and Mail
Freenome与罗氏联手开发癌症筛查检测 - MobiHealthNews
Freenome teams up with Roche for cancer screening tests MobiHealthNews
奥莱玛制药：罗氏MBC数据推动股价翻倍——我主张谨慎行事（纳斯达克：OLMA）- 寻求阿尔法
Olema Pharmaceuticals: Shares Double On Roche's MBC Data - I Preach Caution (NASDAQ:OLMA) Seeking Alpha
Sapphiros与罗氏达成战略合作，为罗氏提供10亿次侧流检测及未来分子即时检测服务 - 雅虎财经
Sapphiros announces a strategic agreement with Roche, providing Roche access to 1 billion lateral flow tests and access to future molecular point-of-care tests Yahoo Fi...
Freenome与罗氏合作，为非美国市场开发癌症筛查技术 - 医疗器械网络
Freenome and Roche partner on cancer screening technology for ex-US markets Medical Device Network
欧盟委员会批准罗氏Lunsumio皮下注射剂用于复发或难治性滤泡性淋巴瘤——雅虎财经
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma Yahoo Finance
罗氏药丸在早期乳腺癌治疗中取得进展——生物制药动态
Roche pill notches win in early breast cancer BioPharma Dive